MarketInOut Stock Screener Log In | Sign Up
 

Liminatus Pharma Inc Cl A

NASDAQ • Healthcare • Biotechnology • Quote as of 07/02/2026
Liminatus Pharma Inc Cl A stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization8.6 mln
Float29.07 mln
Earnings Date10/06/2026

Relative Strength

93 / 100
Top performer

Debt / Equity

-10.85
Negative equity

Dividend Yield

0.00%
No dividend

DPS

0.00
No dividend

Payout Ratio

0%
No payout

ROA

-672
Deeply negative

Business Description

Liminatus Pharma is a California-based drug development company focused on finding new ways to treat cancer. Founded in 2018, the company is working on an antibody treatment designed to help the body's own immune system recognize and attack tumor cells more effectively. Unlike some similar approaches, their lead treatment is engineered to avoid damaging red blood cells, which has been a common problem in this area of research.

Key Fundamentals

EPS-0.25
ROIC-110
ROA-672
EBITDA, mln-10.88
EV / EBITDA-0.45
EV / EBIT-0.45

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 43.94% 99 / 100   
1 Month -26.92% 8 / 100   
2 Months -27.18% 10 / 100   
6 Months -77.87% 3 / 100   
1 Year -98.62% 1 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us